Brief: Diamyd Medical Receives First Regulatory Approval To Start Phase III Trial Diagnode-3 With Diabetes Vaccine Diamyd

Diamyd Medical AB

21/09/2021 14:27

Sept 21 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * DIAMYD MEDICAL RECEIVES FIRST REGULATORY APPROVAL TO START
THE
PHASE III TRIAL DIAGNODE-3 WITH THE DIABETES VACCINE DIAMYD®

Source text for Eikon:  ID:nWkrbjvDvF 
Further company coverage:  DMYDb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))